Arterial chemoembolisation with cisplatin versus epirubicin for hepatocellular carcinoma (ACE 500 study): A multicentre, randomised controlled phase 2/3 trial
Osamu Aramaki, Tadatoshi Takayama, Masamichi Moriguchi, Hidemori Sakamoto, Hiraku Yodono, Norihiro Kokudo, Naoki Yamanaka, Seiji Kawasaki, Yo Sasaki, Keiichi Kubota, Eigo Otsuji, Shinji Tanaka, Yutaka Matsuyama, Masashi Fujii
Topics & Concepts
EpirubicinMedicineHepatocellular carcinomaInternal medicineHazard ratioClinical endpointGastroenterologyPopulationPhases of clinical researchRandomized controlled trialSurgeryConfidence intervalClinical trialCancerBreast cancerEnvironmental healthHepatocellular Carcinoma Treatment and PrognosisOrgan Transplantation Techniques and OutcomesCholangiocarcinoma and Gallbladder Cancer Studies